ProQR Therapeutics is a biopharmaceutical company that focuses on discovering RNA-based therapies for genetic disorders. Their most prominent products, sepofarsen, and ultevursen, are currently undergoing clinical trials to treat various diseases. Additionally, the company has agreements and collaborations with various institutions and companies to discover, develop, and commercialize new medicines for genetic disorders.